
Kanbs Mediserve Private Limited
Provides healthcare services, conducts medical camps and research, manufactures and trades pharmaceutical and healthcare products.
Provides healthcare services, conducts medical camps and research, manufactures and trades pharmaceutical and healthcare products.
Mumbai, Maharashtra, India
+91-XXXXXXXXXX
U74900MH2013PTC239693
239693
Private Limited Indian Non-Government Company
15 Jan 2013
-
-
Unlisted
Roc Mumbai
Name | Designation | Appointment Date | Status |
---|---|---|---|
Jagdishkumar Singh ![]() | Director | 15-Jan-2013 | Current |
Mamta Singh ![]() | Director | 15-Jan-2013 | Current |
Rohit Mishra ![]() | Director | 15-Jan-2013 | Current |
Enhance accessibility to Kanbs Mediserve's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue | |||||||
Revenue from Operations | |||||||
Total Assets | |||||||
Profit or Loss | |||||||
Net Worth | |||||||
EBITDA |
Unlock access to Kanbs Mediserve's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Jagdishkumar Singh and Mamta Singh are mutual person
There are no open charges registered against the company as per our records.
Unlock and access historical data on people associated with Kanbs Mediserve, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Gain comprehensive insights into the Deals and Valuation data of Kanbs Mediserve, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kanbs Mediserve's trajectory.
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
Jagdishkumar Bittan Singh was appointed as a Director was appointed as a Director on 15 Jan 2013 & has been associated with this company since 12 years 2 months .
Mamta Jagdish Singh was appointed as a Director was appointed as a Director on 15 Jan 2013 & has been associated with this company since 12 years 2 months .
Rohit Kumar Nripendra Mishra was appointed as a Director was appointed as a Director on 15 Jan 2013 & has been associated with this company since 12 years 2 months .
Kanbs Mediserve Private Limited was registered on 15 Jan 2013 with Roc Mumbai & aged 12 years 2 months as per MCA records.
Kanbs Mediserve Private Limited was incorporated on 15 Jan 2013.
The authorized share capital of Kanbs Mediserve Private Limited is ₹ 0.10 M and paid-up capital is ₹ 0.10 M.
Currently 3 directors are associated with Kanbs Mediserve Private Limited.
As per Ministry of Corporate Affairs (Mca), the registered address of Kanbs Mediserve Private Limited is 003/ 32 Sanskruti Phase Ii Thakur Complex 90 Feet Road Kandivali East India, Mumbai, Maharashtra, 400101.
The corporate identification number (CIN) of Kanbs Mediserve Private Limited is U74900MH2013PTC239693 and the company number is 239693 as per Ministry of Corporate Affairs (MCA).
Search company & director profiles for free and gain access to critical business data.